Shares of MedTech Acquisition Co. (OTCMKTS:MTACU – Get Free Report) traded up 19.5% during trading on Friday . The company traded as high as $11.35 and last traded at $11.35. Approximately 1,900 shares were traded during trading, an increase of 225% from the average session volume of 585 shares. The stock had previously closed at $9.50.
MedTech Acquisition Stock Up 19.5%
The firm’s fifty day simple moving average is $11.35 and its 200 day simple moving average is $11.35.
About MedTech Acquisition
MedTech Acquisition Corporation is a special purpose acquisition company formed in 2021 under the laws of Delaware and listed on the OTC Markets. The company’s primary objective is to complete a business combination with one or more businesses in the medical technology or life sciences sectors. By structuring as a blank check company, MedTech Acquisition seeks to leverage public market capital and strategic support to accelerate growth in a highly innovative industry.
MedTech Acquisition targets companies operating in areas such as diagnostic imaging, minimally invasive devices, regenerative medicine and digital health.
See Also
- Five stocks we like better than MedTech Acquisition
- 3 Stocks Whose Charts May Be Signaling the Next Big Move
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
